SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/10/11 Unitedhealth Group Inc 10-K 12/31/10 114:19M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.46M 2: EX-10.12 Form of Agreement for Deferred Stock Unit Award HTML 49K 3: EX-10.13 Form of Agreement for Deferred Stock Unit Award HTML 47K 4: EX-10.33 Amendment to Employment Agreement HTML 83K 6: EX-21.1 Subsidiaries of the Company HTML 164K 7: EX-23.1 Consent of Independent Registered Public HTML 35K Accounting Firm 8: EX-24.1 Power of Attorney HTML 42K 5: EX-12.1 Computation of Ratio of Earnings to Fixed Charges HTML 49K 9: EX-31.1 Certification Pursuant to Section 302 of the HTML 49K Sarbanes-Oxley Act of 2002 10: EX-32.1 Certification Pursuant to Section 906 of the HTML 38K Sarbanes-Oxley Act of 2002 87: XML IDEA XML File -- Definitions and References XML 314K 103: XML IDEA XML File -- Filing Summary XML 384K 98: XML.R1 Document and Entity Information XML 226K 99: XML.R2 Consolidated Balance Sheets XML 396K 53: XML.R3 Consolidated Balance Sheets (Parenthetical) XML 175K 62: XML.R4 Consolidated Statements of Operations XML 342K 85: XML.R5 Consolidated Statements of Changes in XML 754K Shareholders' Equity 80: XML.R6 Consolidated Statements of Changes in XML 98K Shareholders' Equity (Parenthetical) 109: XML.R7 Consolidated Statements of Cash Flows XML 564K 28: XML.R8 Description of Business XML 60K 79: XML.R9 Basis of Presentation, Use of Estimates and XML 114K Significant Accounting Policies 24: XML.R10 Investments XML 262K 23: XML.R11 Fair Value XML 195K 52: XML.R12 Property, Equipment and Capitalized Software XML 75K 92: XML.R13 Goodwill and Other Intangible Assets XML 127K 54: XML.R14 Medical Costs and Medical Costs Payable XML 82K 58: XML.R15 Commercial Paper and Long-Term Debt XML 159K 74: XML.R16 Income Taxes XML 140K 114: XML.R17 Shareholders' Equity XML 73K 45: XML.R18 Share-Based Compensation XML 110K 17: XML.R19 Aarp XML 136K 61: XML.R20 Commitments and Contingencies XML 86K 90: XML.R21 Segment Financial Information XML 218K 35: XML.R22 Quarterly Financial Data XML 89K 86: XML.R23 Schedule I XML 172K 59: XML.R24 Basis of Presentation, Use of Estimates and XML 243K Significant Accounting Policies (Policy) 108: XML.R25 Fair Value (Policy) XML 65K 94: XML.R26 Commercial Paper and Long-Term Debt (Policy) XML 59K 65: XML.R27 Aarp (Policy) XML 63K 75: XML.R28 Basis of Presentation, Use of Estimates and XML 76K Significant Accounting Policies (Tables) 22: XML.R29 Investments (Tables) XML 297K 26: XML.R30 Fair Value (Tables) XML 194K 38: XML.R31 Property, Equipment and Capitalized Software XML 73K (Tables) 48: XML.R32 Goodwill and Other Intangible Assets (Tables) XML 144K 73: XML.R33 Medical Costs and Medical Costs Payable (Tables) XML 79K 93: XML.R34 Commercial Paper and Long-Term Debt (Tables) XML 171K 20: XML.R35 Income Taxes (Tables) XML 155K 29: XML.R36 Shareholders' Equity (Tables) XML 57K 100: XML.R37 Share-Based Compensation (Tables) XML 111K 107: XML.R38 Aarp (Tables) XML 137K 66: XML.R39 Commitments and Contingencies (Tables) XML 64K 111: XML.R40 Segment Financial Information (Tables) XML 213K 30: XML.R41 Quarterly Financial Data (Tables) XML 87K 113: XML.R42 Schedule I (Tables) XML 170K 40: XML.R43 Basis of Presentation, Use of Estimates and XML 230K Significant Accounting Policies (Narrative) (Details) 18: XML.R44 Basis of Presentation, Use of Estimates and XML 157K Significant Accounting Policies (Consolidated Balance Sheet) (Details) 39: XML.R45 Basis of Presentation, Use of Estimates and XML 146K Significant Accounting Policies (Useful Lives for Property, Equipment and Capitalized Software) (Details) 89: XML.R46 Investments (Narrative) (Details) XML 185K 106: XML.R47 Investments (Short-term and Long-term Investments) XML 881K (Details) 56: XML.R48 Investments (Fair Value of the Company's XML 840K Mortgage-backed Securities by Credit Rating and Non-U.S. Agency Mortgage-backed Securities by Origination) (Details) 42: XML.R49 Investments (Amortized Cost and Fair Value of XML 176K Available-for-sale Debt Securities by Contractual Maturity) (Details) 71: XML.R50 Investments (Amortized Cost and Fair Value of XML 124K Held-to-maturity Debt Securities by Contractual Maturity) (Details) 21: XML.R51 Investments (Fair Value of Available-for-sale XML 620K Investments with Gross Unrealized Losses by Investment Type and Length of Time that Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details) 77: XML.R52 Investments (Mortgage Backed Securities in an XML 306K Unrealized Loss Position by Credit Rating) (Details) 43: XML.R53 Investments (Net Realized Gains (Losses), Before XML 143K Taxes) (Details) 27: XML.R54 Fair Value (Narrative) (Details) XML 91K 105: XML.R55 Fair Value (Financial Assets and Liabilities, XML 1.45M Excluding AARP, Measured at Fair Value on a Recurring Basis) (Details) 102: XML.R56 Fair Value (Reconciliation of Assets Measured at XML 339K Fair Value on a Recurring Basis Using Level 3 Inputs) (Details) 51: XML.R57 Fair Value (Summary of Fair Value and Carrying XML 233K Value for Certain Financial Instruments for Which it is Practicable to Estimate Fair Value) (Details) 34: XML.R58 Property, Equipment and Capitalized Software XML 97K (Narrative) (Details) 96: XML.R59 Property, Equipment and Capitalized Software XML 155K (Summary of Property, Equipment and Capitalized Software) (Details) 25: XML.R60 Goodwill and Other Intangible Assets (Narrative) XML 98K (Details) 81: XML.R61 Goodwill and Other Intangible Assets (Changes in XML 385K Carrying Amount of Goodwill by Reporting Segment) (Details) 78: XML.R62 Goodwill and Other Intangible Assets (Gross XML 239K Carrying Value, Accumulated Amortization and Net Carrying Value of Other Intangible Assets) (Details) 101: XML.R63 Goodwill and Other Intangible Assets (Finite-Lived XML 207K Intangible Assets Acquired in Business Combinations) (Details) 97: XML.R64 Goodwill and Other Intangible Assets (Amortization XML 87K Expense Relating to Intangible Assets) (Details) 110: XML.R65 Medical Costs and Medical Costs Payable XML 58K (Narrative) (Details) 32: XML.R66 Medical Costs and Medical Costs Payable (The XML 179K Components of the Change in Medical Costs Payable) (Details) 50: XML.R67 Commercial Paper and Long-Term Debt (Narrative) XML 820K (Details) 69: XML.R68 Commercial Paper and Long-Term Debt (Commercial XML 1.27M Paper and Long-Term Debt) (Details) 60: XML.R69 Commercial Paper and Long-Term Debt (Maturities of XML 110K long-term debt) (Details) 70: XML.R70 Commercial Paper and Long-Term Debt (Summary of XML 97K Location and Fair Value of Fair Value Hedges) (Details) 112: XML.R71 Commercial Paper and Long-Term Debt (Effect of XML 73K Changes in Fair Value of Fair Value Hedges) (Details) 33: XML.R72 Income Taxes (Narrative) (Details) XML 168K 41: XML.R73 Income Taxes (Components of the provision for XML 134K income taxes) (Details) 37: XML.R74 Income Taxes (Reconciliation of the tax provision XML 237K at the U.S. Federal Statutory Rate) (Details) 67: XML.R75 Income Taxes (Components of deferred income tax XML 236K assets and liabilities) (Details) 76: XML.R76 Income Taxes (Reconciliation of unrecognized tax XML 128K benefits) (Details) 64: XML.R77 Shareholders' Equity (Narrative) (Details) XML 282K 57: XML.R78 Shareholders' Equity (Schedule of Company's XML 86K dividend payments) (Details) 31: XML.R79 Share-Based Compensation (Narrative) (Details) XML 513K 19: XML.R80 Share-Based Compensation (Stock Option and SAR XML 196K Activity) (Details) 68: XML.R81 Share-Based Compensation (Share-Based Compensation XML 213K Principal Fair Value Assumptions) (Details) 49: XML.R82 Share-Based Compensation (Restricted Share XML 126K Activity) (Details) 63: XML.R83 Aarp (Narrative) (Details) XML 130K 88: XML.R84 Aarp (AARP Program-related Assets and Liabilities) XML 271K (Details) 84: XML.R85 Aarp (AARP Program Financial Assets and XML 1.80M Liabilities Measured at Fair Value on a Recurring Basis) (Details) 46: XML.R86 Commitments and Contingencies (Narrative) XML 230K 91: XML.R87 Commitments and Contingencies (Future Minimum XML 95K Annual Lease Payments, Net of Sublease Income, Under all Noncancelable Operating Leases) (Details) 82: XML.R88 Segment Financial Information (Narrative) XML 85K (Details) 36: XML.R89 Segment Financial Information (Details) XML 2.99M 55: XML.R90 Quarterly Financial Data (Quarterly Financial XML 323K Information) (Details) 83: XML.R91 Schedule I (Condensed Balance Sheets) (Details) XML 908K 44: XML.R92 Schedule I (Condensed Statements of Operations) XML 695K (Details) 95: XML.R93 Schedule I (Condensed Statements of Cash Flows) XML 560K (Details) 47: XML.R94 Schedule I (Narrative) (Details) XML 123K 104: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 2.46M 11: EX-101.INS XBRL Instance -- unh-20101231 XML 3.87M 13: EX-101.CAL XBRL Calculations -- unh-20101231_cal XML 297K 14: EX-101.DEF XBRL Definitions -- unh-20101231_def XML 758K 15: EX-101.LAB XBRL Labels -- unh-20101231_lab XML 1.52M 16: EX-101.PRE XBRL Presentations -- unh-20101231_pre XML 1.30M 12: EX-101.SCH XBRL Schema -- unh-20101231 XSD 282K 72: ZIP XBRL Zipped Folder -- 0001193125-11-030615-xbrl Zip 248K
<?xml version="1.0" encoding="windows-1252"?> | |||||||||||||||||||||
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"> | |||||||||||||||||||||
<Version> 2.2.0.25 </Version> | |||||||||||||||||||||
<hasSegments> false </hasSegments> | |||||||||||||||||||||
<hasScenarios> false </hasScenarios> | |||||||||||||||||||||
<ReportLongName> 40701 - Disclosure - Medical Costs and Medical Costs Payable (Narrative) (Details) </ReportLongName> | |||||||||||||||||||||
<DisplayLabelColumn> true </DisplayLabelColumn> | |||||||||||||||||||||
<ShowElementNames> false </ShowElementNames> | |||||||||||||||||||||
<RoundingOption> In Millions </RoundingOption> | |||||||||||||||||||||
<HasEmbeddedReports> false </HasEmbeddedReports> | |||||||||||||||||||||
<Columns> | |||||||||||||||||||||
<Column> | |||||||||||||||||||||
<Id> 1 </Id> | |||||||||||||||||||||
<IsAbstractGroupTitle> false </IsAbstractGroupTitle> | |||||||||||||||||||||
<LabelColumn> false </LabelColumn> | |||||||||||||||||||||
<CurrencyCode> USD </CurrencyCode> | |||||||||||||||||||||
<FootnoteIndexer/> | |||||||||||||||||||||
<hasSegments> false </hasSegments> | |||||||||||||||||||||
<hasScenarios> false </hasScenarios> | |||||||||||||||||||||
<MCU> | |||||||||||||||||||||
<KeyName> 1/1/2010 - 12/31/2010 USD ($) USD ($) / shares </KeyName> | |||||||||||||||||||||
<CurrencySymbol> $ </CurrencySymbol> | |||||||||||||||||||||
<contextRef> | |||||||||||||||||||||
<ContextID> Duration_1_1_2010_To_12_31_2010 </ContextID> | |||||||||||||||||||||
<EntitySchema> http://www.sec.gov/CIK </EntitySchema> | |||||||||||||||||||||
<EntityValue> 0000731766 </EntityValue> | |||||||||||||||||||||
<PeriodDisplayName/> | |||||||||||||||||||||
<PeriodType> duration </PeriodType> | |||||||||||||||||||||
<PeriodStartDate> 2010-01-01T00:00:00 </PeriodStartDate> | |||||||||||||||||||||
<PeriodEndDate> 2010-12-31T00:00:00 </PeriodEndDate> | |||||||||||||||||||||
<Segments/> | |||||||||||||||||||||
<Scenarios/> | |||||||||||||||||||||
</contextRef> | |||||||||||||||||||||
<UPS> | |||||||||||||||||||||
<UnitProperty> | |||||||||||||||||||||
<UnitID> Unit12 </UnitID> | |||||||||||||||||||||
<UnitType> Standard </UnitType> | |||||||||||||||||||||
<StandardMeasure> | |||||||||||||||||||||
<MeasureSchema> http://www.xbrl.org/2003/iso4217 </MeasureSchema> | |||||||||||||||||||||
<MeasureValue> USD </MeasureValue> | |||||||||||||||||||||
<MeasureNamespace> iso4217 </MeasureNamespace> | |||||||||||||||||||||
</StandardMeasure> | |||||||||||||||||||||
<Scale> 0 </Scale> | |||||||||||||||||||||
</UnitProperty> | |||||||||||||||||||||
<UnitProperty> | |||||||||||||||||||||
<UnitID> Unit13 </UnitID> | |||||||||||||||||||||
<UnitType> Standard </UnitType> | |||||||||||||||||||||
<StandardMeasure> | |||||||||||||||||||||
<MeasureSchema> http://www.xbrl.org/2003/instance </MeasureSchema> | |||||||||||||||||||||
<MeasureValue> pure </MeasureValue> | |||||||||||||||||||||
<MeasureNamespace> xbrli </MeasureNamespace> | |||||||||||||||||||||
</StandardMeasure> | |||||||||||||||||||||
<Scale> 0 </Scale> | |||||||||||||||||||||
</UnitProperty> | |||||||||||||||||||||
<UnitProperty> | |||||||||||||||||||||
<UnitID> Unit1 </UnitID> | |||||||||||||||||||||
<UnitType> Standard </UnitType> | |||||||||||||||||||||
<StandardMeasure> | |||||||||||||||||||||
<MeasureSchema> http://www.xbrl.org/2003/instance </MeasureSchema> | |||||||||||||||||||||
<MeasureValue> shares </MeasureValue> | |||||||||||||||||||||
<MeasureNamespace> xbrli </MeasureNamespace> | |||||||||||||||||||||
</StandardMeasure> | |||||||||||||||||||||
<Scale> 0 </Scale> | |||||||||||||||||||||
</UnitProperty> | |||||||||||||||||||||
<UnitProperty> | |||||||||||||||||||||
<UnitID> Unit14 </UnitID> | |||||||||||||||||||||
<UnitType> Divide </UnitType> | |||||||||||||||||||||
<NumeratorMeasure> | |||||||||||||||||||||
<MeasureSchema> http://www.xbrl.org/2003/iso4217 </MeasureSchema> | |||||||||||||||||||||
<MeasureValue> USD </MeasureValue> | |||||||||||||||||||||
<MeasureNamespace> iso4217 </MeasureNamespace> | |||||||||||||||||||||
</NumeratorMeasure> | |||||||||||||||||||||
<DenominatorMeasure> | |||||||||||||||||||||
<MeasureSchema> http://www.xbrl.org/2003/instance </MeasureSchema> | |||||||||||||||||||||
<MeasureValue> shares </MeasureValue> | |||||||||||||||||||||
<MeasureNamespace> xbrli </MeasureNamespace> | |||||||||||||||||||||
</DenominatorMeasure> | |||||||||||||||||||||
<Scale> 0 </Scale> | |||||||||||||||||||||
</UnitProperty> | |||||||||||||||||||||
</UPS> | |||||||||||||||||||||
<CurrencyCode> USD </CurrencyCode> | |||||||||||||||||||||
<OriginalCurrencyCode> USD </OriginalCurrencyCode> | |||||||||||||||||||||
</MCU> | |||||||||||||||||||||
<CurrencySymbol> $ </CurrencySymbol> | |||||||||||||||||||||
<Labels> | |||||||||||||||||||||
<Label Id="1" Label="12 Months Ended"/> | |||||||||||||||||||||
<Label Id="2" Label="Dec. 31, 2010"/> | |||||||||||||||||||||
</Labels> | |||||||||||||||||||||
</Column> | |||||||||||||||||||||
</Columns> | |||||||||||||||||||||
<Rows> | |||||||||||||||||||||
<Row> | |||||||||||||||||||||
<Id> 2 </Id> | |||||||||||||||||||||
<IsAbstractGroupTitle> true </IsAbstractGroupTitle> | |||||||||||||||||||||
<Level> 0 </Level> | |||||||||||||||||||||
<ElementName> unh_MedicalCostsAndMedicalCostsPayableAbstract </ElementName> | |||||||||||||||||||||
<ElementPrefix> unh </ElementPrefix> | |||||||||||||||||||||
<IsBaseElement> false </IsBaseElement> | |||||||||||||||||||||
<BalanceType> na </BalanceType> | |||||||||||||||||||||
<PeriodType> duration </PeriodType> | |||||||||||||||||||||
<ShortDefinition> Medical Costs And Medical Costs Payable [Abstract] </ShortDefinition> | |||||||||||||||||||||
<IsReportTitle> false </IsReportTitle> | |||||||||||||||||||||
<IsSegmentTitle> false </IsSegmentTitle> | |||||||||||||||||||||
<IsSubReportEnd> false </IsSubReportEnd> | |||||||||||||||||||||
<IsCalendarTitle> false </IsCalendarTitle> | |||||||||||||||||||||
<IsTuple> false </IsTuple> | |||||||||||||||||||||
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow> | |||||||||||||||||||||
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow> | |||||||||||||||||||||
<IsBeginningBalance> false </IsBeginningBalance> | |||||||||||||||||||||
<IsEndingBalance> false </IsEndingBalance> | |||||||||||||||||||||
<IsReverseSign> false </IsReverseSign> | |||||||||||||||||||||
<PreferredLabelRole/> | |||||||||||||||||||||
<FootnoteIndexer/> | |||||||||||||||||||||
<Cells> | |||||||||||||||||||||
<Cell> | |||||||||||||||||||||
<Id> 1 </Id> | |||||||||||||||||||||
<IsNumeric> false </IsNumeric> | |||||||||||||||||||||
<IsRatio> false </IsRatio> | |||||||||||||||||||||
<DisplayZeroAsNone> false </DisplayZeroAsNone> | |||||||||||||||||||||
<NumericAmount> 0 </NumericAmount> | |||||||||||||||||||||
<RoundedNumericAmount> 0 </RoundedNumericAmount> | |||||||||||||||||||||
<NonNumbericText/> | |||||||||||||||||||||
<NonNumericTextHeader/> | |||||||||||||||||||||
<FootnoteIndexer/> | |||||||||||||||||||||
<CurrencyCode/> | |||||||||||||||||||||
<CurrencySymbol/> | |||||||||||||||||||||
<IsIndependantCurrency> false </IsIndependantCurrency> | |||||||||||||||||||||
<ShowCurrencySymbol> false </ShowCurrencySymbol> | |||||||||||||||||||||
<DisplayDateInUSFormat> false </DisplayDateInUSFormat> | |||||||||||||||||||||
<hasSegments> false </hasSegments> | |||||||||||||||||||||
<hasScenarios> false </hasScenarios> | |||||||||||||||||||||
</Cell> | |||||||||||||||||||||
</Cells> | |||||||||||||||||||||
<OriginalInstanceReportColumns/> | |||||||||||||||||||||
<Unit> Other </Unit> | |||||||||||||||||||||
<ElementDataType> xbrli:stringItemType </ElementDataType> | |||||||||||||||||||||
<SimpleDataType> string </SimpleDataType> | |||||||||||||||||||||
<ElementDefenition> Medical Costs And Medical Costs Payable [Abstract] </ElementDefenition> | |||||||||||||||||||||
<IsTotalLabel> false </IsTotalLabel> | |||||||||||||||||||||
<IsEPS> false </IsEPS> | |||||||||||||||||||||
<Label> Medical Costs and Medical Costs Payable </Label> | |||||||||||||||||||||
</Row> | |||||||||||||||||||||
<Row> | |||||||||||||||||||||
<Id> 3 </Id> | |||||||||||||||||||||
<IsAbstractGroupTitle> false </IsAbstractGroupTitle> | |||||||||||||||||||||
<Level> 0 </Level> | |||||||||||||||||||||
<ElementName> unh_NetFavorableMedicalCostDevelopment </ElementName> | |||||||||||||||||||||
<ElementPrefix> unh </ElementPrefix> | |||||||||||||||||||||
<IsBaseElement> false </IsBaseElement> | |||||||||||||||||||||
<BalanceType> debit </BalanceType> | |||||||||||||||||||||
<PeriodType> duration </PeriodType> | |||||||||||||||||||||
<ShortDefinition> Net favorable medical cost development </ShortDefinition> | |||||||||||||||||||||
<IsReportTitle> false </IsReportTitle> | |||||||||||||||||||||
<IsSegmentTitle> false </IsSegmentTitle> | |||||||||||||||||||||
<IsSubReportEnd> false </IsSubReportEnd> | |||||||||||||||||||||
<IsCalendarTitle> false </IsCalendarTitle> | |||||||||||||||||||||
<IsTuple> false </IsTuple> | |||||||||||||||||||||
<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow> | |||||||||||||||||||||
<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow> | |||||||||||||||||||||
<IsBeginningBalance> false </IsBeginningBalance> | |||||||||||||||||||||
<IsEndingBalance> false </IsEndingBalance> | |||||||||||||||||||||
<IsReverseSign> false </IsReverseSign> | |||||||||||||||||||||
<PreferredLabelRole/> | |||||||||||||||||||||
<FootnoteIndexer/> | |||||||||||||||||||||
<Cells> | |||||||||||||||||||||
<Cell> | |||||||||||||||||||||
<Id> 1 </Id> | |||||||||||||||||||||
<IsNumeric> true </IsNumeric> | |||||||||||||||||||||
<IsRatio> false </IsRatio> | |||||||||||||||||||||
<DisplayZeroAsNone> false </DisplayZeroAsNone> | |||||||||||||||||||||
<NumericAmount> 800000000 </NumericAmount> | |||||||||||||||||||||
<RoundedNumericAmount> 800 </RoundedNumericAmount> | |||||||||||||||||||||
<NonNumbericText/> | |||||||||||||||||||||
<NonNumericTextHeader/> | |||||||||||||||||||||
<FootnoteIndexer/> | |||||||||||||||||||||
<CurrencyCode/> | |||||||||||||||||||||
<CurrencySymbol/> | |||||||||||||||||||||
<IsIndependantCurrency> false </IsIndependantCurrency> | |||||||||||||||||||||
<ShowCurrencySymbol> true </ShowCurrencySymbol> | |||||||||||||||||||||
<DisplayDateInUSFormat> false </DisplayDateInUSFormat> | |||||||||||||||||||||
<hasSegments> false </hasSegments> | |||||||||||||||||||||
<hasScenarios> false </hasScenarios> | |||||||||||||||||||||
</Cell> | |||||||||||||||||||||
</Cells> | |||||||||||||||||||||
<OriginalInstanceReportColumns/> | |||||||||||||||||||||
<Unit> Monetary </Unit> | |||||||||||||||||||||
<ElementDataType> xbrli:monetaryItemType </ElementDataType> | |||||||||||||||||||||
<SimpleDataType> monetary </SimpleDataType> | |||||||||||||||||||||
<ElementDefenition> Net favorable medical cost development </ElementDefenition> | |||||||||||||||||||||
<ElementReferences> No authoritative reference available. </ElementReferences> | |||||||||||||||||||||
<IsTotalLabel> false </IsTotalLabel> | |||||||||||||||||||||
<IsEPS> false </IsEPS> | |||||||||||||||||||||
<Label> Net favorable medical cost development </Label> | |||||||||||||||||||||
</Row> | |||||||||||||||||||||
</Rows> | |||||||||||||||||||||
<Footnotes/> | |||||||||||||||||||||
<NumberOfCols> 1 </NumberOfCols> | |||||||||||||||||||||
<NumberOfRows> 2 </NumberOfRows> | |||||||||||||||||||||
<ReportName> Medical Costs and Medical Costs Payable (Narrative) (Details) (USD $) </ReportName> | |||||||||||||||||||||
<MonetaryRoundingLevel> Millions </MonetaryRoundingLevel> | |||||||||||||||||||||
<SharesRoundingLevel> UnKnown </SharesRoundingLevel> | |||||||||||||||||||||
<PerShareRoundingLevel> UnKnown </PerShareRoundingLevel> | |||||||||||||||||||||
<ExchangeRateRoundingLevel> UnKnown </ExchangeRateRoundingLevel> | |||||||||||||||||||||
<HasCustomUnits> false </HasCustomUnits> | |||||||||||||||||||||
<SharesShouldBeRounded> true </SharesShouldBeRounded> | |||||||||||||||||||||
</InstanceReport> |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/05/11 SEC UPLOAD¶ 10/06/17 1:46K Unitedhealth Group Inc. 4/27/11 SEC UPLOAD¶ 10/06/17 1:67K Unitedhealth Group Inc. |